Whole body norepinephrine kinetics in ANG II-salt hypertension in the rat

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 294, Issue 4, 2008, Pages

  King, Andrew J ^a   Novotny, Martin ^b   Swain, Greg M ^b   Fink, Gregory D ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Norepinephrine clearance; Norepinephrine spillover; Salt sensitive hypertension; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN II; NORADRENALIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; ISOTOPE DILUTION ASSAY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; NORADRENALIN URINE LEVEL; PRIORITY JOURNAL; RAT; SALT INTAKE;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HEART RATE; HYPERTENSION; INFUSION PUMPS, IMPLANTABLE; KINETICS; MALE; NOREPINEPHRINE; RADIOISOTOPE DILUTION TECHNIQUE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE, DIETARY; SYMPATHETIC NERVOUS SYSTEM; TRITIUM;

EID: 41749110029     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00819.2007     Document Type: Article

References (59)

1. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 14: 177-183, 1989.
2. Arribas SM, Alonso MJ, Marin J, Fernandes F, Llergo JL, Sanchez-Ferrer CF, Salaices M. Noradrenergic transmission in the tail artery of hypertensive rats transgenic for the mouse renin gene Ren-2. J Auton Pharmacol 16: 69-77, 1996.
3. Bechir M, Enseleit F, Chenevard R, Luscher TF, Noll G. Effect of losartan on muscle sympathetic activity and baroreceptor function in systemic hypertension. Am J Cardiol 95: 129-131, 2005.
4. Brooks VL, Haywood JR, Johnson AK. Translation of salt retention to central activation of the sympathetic nervous system in hypertension. Clin Exp Pharmacol Physiol 32: 426-432, 2005.
5. Bruner CA, Fink GD. Neurohumoral contributions to chronic angiotensin-induced hypertension. Am J Physiol Heart Circ Physiol 250: H52-H61, 1986.
6. Cabassi A, Vinci S, Cantoni AM, Quartieri F, Moschini L, Cavazzini S, Cavatorta A, Borghetti A. Sympathetic activation in adipose tissue and skeletal muscle of hypertensive rats. Hypertension 39: 656-661, 2002.
7. Campese VM. Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension 23: 531-550, 1994.
8. Campese VM, Karubian F, Chervu I, Parise M, Sarkies N, Bigazzi R. Pressor reactivity to norepinephrine and angiotensin in salt-sensitive hypertensive patients. Hypertension 21: 301-307, 1993.
9. Campese VM, Romoff MS, Levitan D, Saglikes Y, Friedler RM, Massry SG. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int 21: 371-378, 1982.
10. Carlson SH, Roysomutti S, Peng N, Wyss JM. The role of the central nervous system in NaCl-sensitive hypertension in spontaneously hypertensive rats. Am J Hypertens 14: 155S-162S, 2001.
11. Chen YF, Meng QC, Wyss JM, Jin H, Oparil S. High NaCl diet reduces hypothalamic norepinephrine turnover in hypertensive rats. Hypertension 11: 55-62, 1988.
12. Coruzzi P, Parati G, Brambilla L, Brambilla V, Gualerzi M, Novarini A, Castiglioni P, Di Rienzo M. Effects of salt sensitivity on neural cardiovascular regulation in essential hypertension. Hypertension 46: 1321-1326, 2005.
13. Eisenhofer G. Sympathetic nerve function-assessment by radioisotope dilution analysis. Clin Auton Res 15: 264-283, 2005.
14. Esler M. The sympathetic system and hypertension. Am J Hypertens 13: 99S-105S, 2000.
15. Esler M, Ferrier C, Lambert G, Eisenhofer G, Cox H, Jennings G. Biochemical evidence of sympathetic hyperactivity in human hypertension. Hypertension 17: III29 -III35, 1991.
16. Esler M, Jackman G, Bobik A, Kelleher D, Jennings G, Leonard P, Skews H, Korner P. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci 25: 1461-1470, 1979.
17. Esler M, Jennings G, Korner P, Blombery P, Burke F, Willett I, Leonard P. Total, and organ-specific, noradrenaline plasma kinetics in essential hypertension. Clin Exp Hypertens A 6: 507-521, 1984.
18. Esler M, Lambert G, Jennings G. Regional norepinephrine turnover in human hypertension. Clin Exp Hypertens A 11 Suppl 1: 75-89, 1989.
19. Esler M, Leonard P, O'Dea K, Jackman G, Jennings G, Korner P. Biochemical quantification of sympathetic nervous activity in humans using radiotracer methodology: fallibility of plasma noradrenaline measurements. J Cardiovasc Pharmacol 4 Suppl 1: S152-S157, 1982.
20. Esler M, Rumantir M, Kaye D, Jennings G, Hastings J, Socratous F, Lambert G. Sympathetic nerve biology in essential hypertension. Clin Exp Pharmacol Physiol 28: 986-989, 2001.
21. Ferrier C, Esler MD, Eisenhofer G, Wallin BG, Horne M, Cox HS, Lambert G, Jennings GL. Increased norepinephrine spillover into the jugular veins in essential hypertension. Hypertension 19: 62-69, 1992.
22. Fink GD, Bruner CA, Mangiapane ML. Area postrema is critical for angiotensin-induced hypertension in rats. Hypertension 9: 355-361, 1987.
23. Fujita T, Henry WL, Bartter FC, Lake CR, Delea CS. Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med 69: 334-344, 1980.
24. Genain CP, Reddy SR, Ott CE, Van Loon GR, Kotchen TA. Failure of salt loading to inhibit tissue norepinephrine turnover in prehypertensive Dahl salt-sensitive rats. Hypertension 12: 568-573, 1988.
25. Gill JR Jr, Gullner G, Lake CR, Lakatua DJ, Lan G. Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension. Hypertension 11: 312-319, 1988.
26. Gorbea-Oppliger VJ, Fink GD. Clonidine reverses the slowly developing hypertension produced by low doses of angiotensin II. Hypertension 23: 844-847, 1994.
27. Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension 31: 64-67, 1998.
28. Grassi G, Seravalle G, Dell'Oro R, Trevano FQ, Bombelli M, Scopelliti F, Facchini A, Mancia G. Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study. J Hypertens 21: 1761-1769, 2003.
29. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 7: 335-346, 2006.
30. Holmes C, Eisenhofer G, Goldstein DS. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 653: 131-138, 1994.
31. Keeton TK, Biediger AM. The measurement of norepinephrine clearance and spillover rate into plasma in conscious spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol 338: 350-360, 1988.
32. King AJ, Fink GD. Chronic low-dose angiotensin II infusion increases venomotor tone by neurogenic mechanisms. Hypertension 48: 927-933, 2006.
33. King AJ, Osborn JW, Fink GD. Splanchnic circulation is a critical neural target in angiotensin II salt hypertension in rats. Hypertension 50: 547-556, 2007.
34. Kline RL, Chow KY, Mercer PF. Does enhanced sympathetic tone contribute to angiotensin II hypertension in rats? Eur J Pharmacol 184: 109-118, 1990.
35. Koepke JP, DiBona GF. High sodium intake enhances renal nerve and antinatriuretic responses to stress in spontaneously hypertensive rats. Hypertension 7: 357-363, 1985.
36. Koolen MI, Bussemaker-Verduyn den Boer E., and van Brummelen P. Clinical biochemical and haemodynamic correlates of sodium sensitivity in essential hypertension. J Hypertens Suppl 1: 21-23, 1983.
37. Kotchen TA, Blehschmidt NG, Reddy SR. Effect of dietary NaCl on norepinephrine turnover in the Dahl rat. J Lab Clin Med 117: 383-389, 1991.
38. Krum H, Lambert E, Windebank E, Campbell DJ, Esler M. Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circ Physiol 290: H1706-H1712, 2006.
39. Lau YE, Galligan JJ, Kreulen DL, Fink GD. Activation of ETB receptors increases superoxide levels in sympathetic ganglia in vivo. Am J Physiol Regul Integr Comp Physiol 290: R90-R95, 2006.
40. Luft FC, Wilcox CS, Unger T, Kuhn R, Demmert G, Rohmeiss P, Ganten D, Sterzel RB. Angiotensin-induced hypertension in the rat. Sympathetic nerve activity and prostaglandins. Hypertension 14: 396-403, 1989.
41. Majewski H, Hedler L, Starke K. Evidence for a physiological role of presynaptic alpha-adrenoceptors: modulation of noradrenaline release in the pithed rabbit. Naunyn Schmiedebergs Arch Pharmacol 324: 256-263, 1983.
42. McBryde FD, Guild SJ, Barrett CJ, Osborn JW, Malpas SC. Angiotensin II-based hypertension and the sympathetic nervous system: the role of dose and increased dietary salt in rabbits. Exp Physiol 92: 831-840, 2007.
43. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, Inenaga T, Kimura G. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 350: 1734-1737, 1997.
44. Neumann J, Ligtenberg G, Klein IH, Boer P, Oey PL, Koomans HA, Blankestijn PJ. Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension 49: 506-510, 2007.
45. Nishio I, Shima H, Tsuda K, Hano T, Masuyama Y. Relationship between the sympathetic nervous system and sodium potassium adenosine triphosphatase inhibitor in salt-sensitive patients with essential hypertension. J Hypertens Suppl 6: S216-S218, 1988.
46. O'Donaughy TL, Brooks VL. Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels. Hypertension 47: 680-685, 2006.
47. O'Donaughy TL, Qi Y, Brooks VL. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats. Hypertension 48: 658-663, 2006.
48. Osborn JW, Fink GD, Sved AF, Toney GM, Raizada MK. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep 9: 228-235, 2007.
49. Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol Endocrinol Metab 262: E763-E778, 1992.
50. Sanders BJ, Johnson AK. Lesions of the anteroventral third ventricle prevent salt-induced hypertension in the borderline hypertensive rat. Hypertension 14: 619-622, 1989.
51. Sato Y, Ogata E, Fujita T. Role of chloride in angiotensin II-induced salt-sensitive hypertension. Hypertension 18: 622-629, 1991.
52. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Hastings J, Aggarwal A, Esler MD. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation. Hypertension 43: 169-175, 2004.
53. Skrabal F, Herholz H, Neumayr M, Hamberger L, Ledochowski M, Sporer H, Hortnagl H, Schwarz S, Schonitzer D. Salt sensitivity in humans is linked to enhanced sympathetic responsiveness and to enhanced proximal tubular reabsorption. Hypertension 6: 152-158, 1984.
54. Takeda K, Bunag RD. Augmented sympathetic nerve activity and pressor responsiveness in DOCA hypertensive rats. Hypertension 2: 97-101, 1980.
55. Thoren P, Ricksten SE. Recordings of renal and splanchnic sympathetic nervous activity in normotensive and spontaneously hypertensive rats. Clin Sci (Lond) 57 Suppl 5: 197s-199s, 1979.
56. Toney GM, Chen QH, Cato MJ, Stocker SD. Central osmotic regulation of sympathetic nerve activity. Acta Physiol Scand 177: 43-55, 2003.
57. Vaz M, Cox HS, Kaye DM, Turner AG, Jennings GL, Esler MD. Fallibility of plasma noradrenaline measurements in studying postprandial sympathetic nervous responses. J Auton Nerv Syst 56: 97-104, 1995.
58. Voisin DL, Bourque CW. Integration of sodium and osmosensory signals in vasopressin neurons. Trends Neurosci 25: 199-205, 2002.
59. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 27: 481-490, 1996.